Pain Alliance Europe

PAE is a member of the patient consultation with the European Medicines Agency EMA
Works closely with the European Pain Federation EFIC
We are members of many European Organisations including European Federation of Neurological Associations (EFNA), and Active Citizens Network (ACN)

None declared

Does not represent commercial interests

Jan 2023 - Dec 2023

Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.

41,770€

On 31/12/2022 we closed the year with a plus of 17.047,51 euros while on 31/12/2023 with a loss of 4.641,96. Given that PAE managed the BMP Grant (30.000 from Grunenthal in 2023 would go directly into the grant), paying out the grant winners sums of money every year, we have been having a plus year (for example 2022) and a loss year (for example 2023). This will be amended from 2024 on because the pain grant will be relaunched and all management will be done from PAE, while making sure there will always be a % of the grant that will be going directly to support core activities. This way it will balance out our positive and negative results every other year.

None declared

Disability,Cancer

In partnership with the European Pain Federation (EFIC) in the Societal Impact of Pain Platform (SIP) we hold events which also launch our position papers in response to EU policy that involves the societal impact of pain including Comprehensive approach to Mental Health, EU Health Data Space Plan, Healthy Workplaces, the Beating Cancer Plan.

On 10 October 2023, World Mental Health Day, SIP hosted the 'Pain and Mental Health: A Societal Impact of Pain (SIP) Event' at the European Parliament. We launched our Joint Statement on Pain and Mental Health.
Invited MEPs, and experts shared their insights at a panel discussion on the close relationship between pain and mental health, the quality of and access to safe pain management, the link between pain, mental health and employment, and how these aspects can be integrated into mental health policies.

In May 2023 Psychedelic Access and Research European Alliance (PAREA) formed a Members of the European Parliament Action Group for the Medical Use of Psychedelics (MEP AG). PAE is a founding member. On November 6th 2023 PAREA held an event in the Parliament titled 'Innovating mental Health in the EU Pharma Legislation: Regulatory Pathways for Psychedelic Therapies' to launch the policy paper: “Unmet Medical Needs: Aligning Medical Innovation with Societal Health Needs”.

None declared

2 meetings found. Download meetings

The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.

• Date	08 Mar 2019	Location	Brussels
  Subject	Societal and economic impact of chronic pain
  Cabinet	Cabinet of Vice-President Jyrki Katainen
  Portfolio	Jobs, Growth, Investment and Competitiveness
  Attending	Marika Lautso-Mousnier (Cabinet member)

• Date	19 Feb 2015	Location	Brussels, Belgium
  Subject	Range of brain related deseases
  Cabinet	Cabinet of Commissioner Vytenis Andriukaitis
  Portfolio	Health & Food Safety
  Attending	Arunas Vinciunas (Cabinet member)
  Other Lobbyists	European Federation of Neurological Associations